Cats with chronic kidney disease are prone to developing a secondary condition called nonregenerative anemia, a potentially fatal complication that keeps down the production of red blood cells needed to carry oxygen from the lungs to all the body’s tissues. It occurs because the compromised kidneys produce less of a hormone called erythropoietin, which helps the bone marrow produce red blood cells. But a new drug, Varenzin-CA1, treats the problem by increasing erythropoietin production.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Tufts Catnip
Get the next year of TUFTS CATNIP for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 44%. It's like getting 5 months FREE!
